Sponsor or institution

Clinical trials and research at Grand Hôpital de Charleroi

As of November 12, 2026, Find a Trial lists 5 clinical trials run by Grand Hôpital de Charleroi that are recruiting, in Belgium. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Blood samples to test the TST79 molecular test for cancer patients — Charleroi, Hainaut Recruiting Oct 9, 2026
AI tool to spot and reduce missed doses of oral medicines for Non-Hodgkin lymphoma patients — Charleroi, Hainaut Recruiting Apr 22, 2026
Using the JAPET.W+ lumbar exoskeleton to help rehabilitate non-specific mechanical low back pain — Charleroi, Hainaut Recruiting Dec 5, 2024
Understanding how stroke patients perceive their upper limb use during rehabilitation — Charleroi, Hainaut and 1 other locations Recruiting Aug 26, 2024
Observational study on predicting treatment response in diffuse large B-cell lymphoma — Charleroi, Hainaut Recruiting Feb 5, 2024

All recruiting trials (5)

Quick answers

How many clinical trials run by Grand Hôpital de Charleroi are recruiting right now?

5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Belgium. Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.